Aptorum Group Limited (APM)

NCM – Real vaqt narxi. Valyuta: USD

0.77

-0.00 (-0.32%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

0.76

-0.01 (-1.63%)

Bozordan keyin: Jun 26, 2026, 6:09 PM EDT

10.06.2026

Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences

NEW YORK, NY, June 10, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group" or "Aptorum"), a biopharmaceutical company dedicated to addressing unmet medical needs, today announced that at its shareholder meeting held on June 9, 2026, its shareholders voted to approve the proposed merger transaction with DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases.

13.05.2026

Andean Precious Metals Corp. (APM:CA) Q1 2026 Earnings Call Transcript

25.03.2026

Andean Precious Metals Corp. (APM:CA) Q4 2025 Earnings Call Transcript

10.03.2026

Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania

NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, March 10, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, and DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced the publication of a paper by Giliberto, et. al. titled "Development of microRNA-Based Glioblastoma Biomarkers Using Blood Plasma Specimens” in Diagnostics, (https://doi.org/10.3390/diagnostics16050791), a leading peer-reviewed journal focused on clinical diagnostics and biomarker research.

02.02.2026

Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease

NEW YORK, NY; NEW HAVEN, CT; PRINCETON, NJ, and TAIPEI, TAIWAN, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, and Instant NanoBiosensors Co., Ltd. (“INB”), a developer of cutting-edge biosensor platforms designed to improve biomedical research and diagnostic processes through simple, reliable, and affordable detection solutions, today announced a collaboration between DiamiR and INB to validate INB's automated APOE testing platform for clinical use in DiamiR's CLIA-certified, CAP-accredited clinical laboratory.

19.11.2025

DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference

NEW YORK, NY, NEW HAVEN, CT, and PRINCETON, N.J., Nov. 19, 2025 (GLOBE NEWSWIRE) -- DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, and Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, announce two poster presentations at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference, taking place December 1-4, 2025, in San Diego, CA, and online.

12.11.2025

Andean Precious Metals Corp. (APM:CA) Q3 2025 Earnings Call Transcript

Andean Precious Metals Corp. ( APM:CA ) Q3 2025 Earnings Call November 12, 2025 9:00 AM EST Company Participants Amanda Mallough Alberto Morales - Founder, CEO & Executive Chairman Yohann Bouchard - President & Director Juan Sandoval - Chief Financial Officer Dom Kizek Conference Call Participants Omeet Singh - SCP Resource Finance LP, Research Division Allison Carson - Desjardins Securities Inc., Research Division Ben Pirie - Atrium Research Corporation Presentation Operator Hello, and welcome to the Andean Precious Metals Third Quarter Conference Call and Webcast. [Operator Instructions] I would now like to turn the conference over to Amanda Mallough, Director of Investor Relations.

Videolar

No Data

There is no data to display

Press-relizlar

10.06.2026

Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences

10.03.2026

Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania

02.02.2026

Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease

19.11.2025

DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference

Aptorum Group Limited (APM)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Aptorum Group Limited (APM)

Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences

Andean Precious Metals Corp. (APM:CA) Q1 2026 Earnings Call Transcript

Andean Precious Metals Corp. (APM:CA) Q4 2025 Earnings Call Transcript

Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania

Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease

DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference

Andean Precious Metals Corp. (APM:CA) Q3 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences

Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania

Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease

DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference

Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences

Andean Precious Metals Corp. (APM:CA) Q1 2026 Earnings Call Transcript

Andean Precious Metals Corp. (APM:CA) Q4 2025 Earnings Call Transcript

Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania

Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease

DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference

Andean Precious Metals Corp. (APM:CA) Q3 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences

Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania

Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease

DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference

Search stocks

Aptorum Group Limited (APM)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Aptorum Group Limited (APM)

Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences

Andean Precious Metals Corp. (APM:CA) Q1 2026 Earnings Call Transcript

Andean Precious Metals Corp. (APM:CA) Q4 2025 Earnings Call Transcript

Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania

Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease

DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference

Andean Precious Metals Corp. (APM:CA) Q3 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences

Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania

Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease

DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference

Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences

Andean Precious Metals Corp. (APM:CA) Q1 2026 Earnings Call Transcript

Andean Precious Metals Corp. (APM:CA) Q4 2025 Earnings Call Transcript

Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania

Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease

DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference

Andean Precious Metals Corp. (APM:CA) Q3 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences

Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania

Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB's Automated APOE Testing Platform for Alzheimer's Disease

DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference